NFC(000758) 证券时报网·2024-12-29 13:33Group 1 - China Nuclear Technology plans to acquire 71.97% stake in Xi'an China Nuclear Instrument Co., Ltd. through share issuance, which is expected to constitute a major asset restructuring [1] - Weikang Pharmaceutical and its actual controller are under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [2] - Yituo Co. announced a 2.71% year-on-year increase in tractor sales for 2024, totaling 74,300 units, while diesel engine sales decreased by 3.32% to 146,000 units [3] Group 2 - Jinchuan Group intends to sell 100% equity of its subsidiary Jiangsu Mingxin Transportation Equipment Co., Ltd. for 400 million yuan, aiming to optimize asset structure and increase cash flow [4][6] - Lin Yang Energy has pre-won a procurement project from Southern Power Grid, with an estimated total bid amount of approximately 278 million yuan, expected to positively impact 2025 performance [5] - Hengrui Medicine signed a licensing agreement for the SHR-4849 project with IDEAYA Biosciences, receiving an upfront payment of 75 million USD and potential milestone payments [10] Group 3 - China Nonferrous Metals Group plans to increase its stake in the company by 100 million to 200 million yuan, supported by a loan from Agricultural Bank [11] - Han Yu Group's major shareholders plan to reduce their holdings by up to 1.6% of the company's shares [8][12] - Tian Yong Intelligent's shareholder plans to reduce holdings by up to 2.27% of the company's shares [13]